694 related articles for article (PubMed ID: 15814658)
1. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
2. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
[TBL] [Abstract][Full Text] [Related]
3. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
4. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
6. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
7. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network.
Bindra RS; Glazer PM
Cancer Lett; 2007 Jul; 252(1):93-103. PubMed ID: 17275176
[TBL] [Abstract][Full Text] [Related]
8. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
D'Agnano I; Valentini A; Fornari C; Bucci B; Starace G; Felsani A; Citro G
Oncogene; 2001 May; 20(22):2814-25. PubMed ID: 11420693
[TBL] [Abstract][Full Text] [Related]
9. Relation between DNA ploidy status and the expression of the DNA-mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastases.
Korabiowska M; Ruschenburg I; Schlott T; Kubitz A; Brinck U; Droese M
Diagn Cytopathol; 2001 Mar; 24(3):157-62. PubMed ID: 11241897
[TBL] [Abstract][Full Text] [Related]
10. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
Biroccio A; Benassi B; Amodei S; Gabellini C; Del Bufalo D; Zupi G
Mol Pharmacol; 2001 Jul; 60(1):174-82. PubMed ID: 11408612
[TBL] [Abstract][Full Text] [Related]
11. The mismatch repair system is required for S-phase checkpoint activation.
Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
13. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract][Full Text] [Related]
14. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
15. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
Christmann M; Kaina B
J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
[TBL] [Abstract][Full Text] [Related]
18. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
[TBL] [Abstract][Full Text] [Related]
20. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]